Previous Article | Next Article ![]()
Infect. Immun., Aug 1995, 2919-2923, Vol 63, No. 8
A Vecchiarelli, C Retini, D Pietrella, C Monari, C Tascini, T Beccari and TR Kozel
The regulation by Cryptococcus neoformans encapsulation of interleukin 1
beta (IL-1 beta) and tumor necrosis factor alpha (TNF-alpha) production by
human monocytes was investigated. By using encapsulated and acapsular C.
neoformans, we demonstrated that both strains induce cytokine production,
although the acapsular strain was a better stimulator than the thinly
encapsulated strain. The cytokine levels produced by cells stimulated by
the two strains were lower and followed a different kinetic than those
stimulated by lipopolysaccharide (LPS). Purified capsular polysaccharide
inhibits TNF-alpha secretion induced by LPS or acapsular C. neoformans. In
contrast, no regulator effect on IL-1 beta was observed when LPS was used.
The secretory response of these cytokines follows different pathways of
macrophage activation; in fact, complete inhibition of TNF-alpha does not
affect IL-1 beta production and vice versa. These data indicate that
purified capsular polysaccharide of C. neoformans could contribute to the
in vivo progress of cryptococcosis by suppressing cytokine production of
macrophages and suggest that a therapeutic approach to address the
suppressive effect of cryptococal polysaccharide could be devised.
Copyright © 1995, American Society for Microbiology
Downregulation by cryptococcal polysaccharide of tumor necrosis factor alpha and interleukin-1 beta secretion from human monocytes
Department of Experimental Medicine and Biochemical Sciences, University of Perugia, Italy.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|